Medical News Today: How to treat peripheral neuropathy naturally
Peripheral neuropathy involves damage to the peripheral nerves. This can cause various sensations, including pain. Here, learn more about the symptoms and causes and which natural treatments may help. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 24, 2019 Category: Consumer Health News Tags: Neurology / Neuroscience Source Type: news
Balance training as a promising intervention for reducing the risk of fall in elderly patients with chemotherapy-induced peripheral neuropathy - Mortazavi H.
[Abstract unavailable]
Language: en... (Source: SafetyLit)
Source: SafetyLit - October 16, 2019 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news
Textured shoe insoles to improve balance performance in adults with diabetic peripheral neuropathy: study protocol for a randomised controlled trial - Hatton AL, Gane EM, Maharaj JN, Burns J, Paton J, Kerr G, Rome K.
INTRODUCTION: Peripheral neuropathy is a major risk factor for falls in adults with diabetes. Innovative footwear devices which artificially manipulate the sensory environment at the feet, such as textured shoe insoles, are emerging as an attractive option... (Source: SafetyLit)
Source: SafetyLit - July 23, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Chemotherapy-induced peripheral neuropathy: association with increased risk of falls and injuries - Autissier E.
BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and degenerative side effect of many commonly used chemotherapy agents. Symptoms manifest as sensory and motor neuropathies. CIPN may necessitate chemotherapy dose reduction or... (Source: SafetyLit)
Source: SafetyLit - July 23, 2019 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
FDA Approves First Generics of Lyrica
July 22, 2019 -- On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 22, 2019 Category: Pharmaceuticals Source Type: news
FDA approves first generics of Lyrica
On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associated with diabetic peripheral neuropathy, for the management of postherpetic neuralgia, as an adjunctive therapy for the treatment of partial onset seizures in patients 17 years of age and older, for the management of fibromyalgia, and for the management of neuropathic pain associated with spinal cord injury. (Source: World Pharma News)
Source: World Pharma News - July 22, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news
Looking for an optimal pedal layout to improve the driving performance of patients with diabetic peripheral neuropathy - Ma S, Wu C, Zhang J, Zeng X, Zhao G, Sun X.
This study sought to investigate how diabetic peripheral neuropathy (DPN), a common complication of diabetes... (Source: SafetyLit)
Source: SafetyLit - July 11, 2019 Category: International Medicine & Public Health Tags: Engineering, Physics, Structural Soundness and Failure Source Type: news
Avastin Improves Quality of Life for Mesothelioma Patients
A research team from France has documented the health-related quality-of-life benefits of adding Avastin (bevacizumab) to chemotherapy for pleural mesothelioma patients, endorsing its addition to standard-of-care treatment.
The recent quality-of-life analysis was a secondary endpoint of an earlier, multicenter clinical trial in France that showed an almost three-month median survival improvement when adding Avastin.
The latest study demonstrated that adding Avastin to cisplatin and Alimta (pemetrexed) did not negatively impact quality of life — a problem with several other cancers because of the increased toxicity.
“Co...
Source: Asbestos and Mesothelioma News - July 8, 2019 Category: Environmental Health Authors: Matt Mauney Source Type: news
Women more likely to develop diabetic neuropathy
Findings, published inBMJ Open Diabetes Research& Care, suggest that being female, rather than low vitamin D levels, is linked to a greater risk of peripheral neuropathy in type 2 diabetes.Endocrinology Advisor (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 3, 2019 Category: Endocrinology Source Type: news
Genetic marker linked to increased risk of diabetic peripheral neuropathy
(Joslin Diabetes Center) This is the first real effort to have a genome wide search for genes predisposing to diabetic peripheral neuropathy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 11, 2019 Category: International Medicine & Public Health Source Type: news
How Common is Restless Legs Syndrome in Children?
Discussion
Restless legs syndrome (RLS) is also known as Willis-Ekbom disease.
RLS is a clinical diagnosis with criteria being:
1. An urge to move the legs usually accompanied by uncomfortable and unpleasant sensations in the lower extremities (Note: sometimes other body parts can be affected)
2. The urge to move begins or worsens when sitting or lying down
3. The urge to move is partially or totally relieved by movement (Note: relief by activity may not be noticable if severely affected but must have been previously present)
4. The urge to move the legs and any accompanying unpleasant sensations during rest or in activ...
Source: PediatricEducation.org - June 10, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
i-Fect Scores Again
This study is the first to demonstrate that the stabilization of HIF1A expression underpins the development of bortezomib-induced neuropathic pain. Crucially, these findings reveal that the initiation and maintenance of bortezomib-induced neuropathic pain are regulated by distinct mechanisms. (Source: Neuromics)
Source: Neuromics - May 13, 2019 Category: Neuroscience Tags: chemotherapy i-Fect RNAi siRNA siRNA delivery in-vivo Source Type: news
i-Fect in Action
This study is the first to demonstrate that the stabilization of HIF1A expression underpins the development of bortezomib-induced neuropathic pain. Crucially, these findings reveal that the initiation and maintenance of bortezomib-induced neuropathic pain are regulated by distinct mechanisms.Looking to up your odds for high percentage siRNA Transfection? Try i-Fect. (Source: siRNA and DsiRNA Transfection Efficiency)
Source: siRNA and DsiRNA Transfection Efficiency - May 9, 2019 Category: Neuroscience Tags: Chemotherapy i-Fect in vivo RNAi neuropathic pain siRNA delivery in-vivo Source Type: news
Oral Fluoroquinolones Carry Small Risk of Peripheral Neuropathy Oral Fluoroquinolones Carry Small Risk of Peripheral Neuropathy
Oral fluoroquinolone exposure is associated with a small increase in risk of peripheral neuropathy, according to findings from The Health Improvement Network (THIN) database.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - May 3, 2019 Category: Surgery Tags: Infectious Diseases News Source Type: news
NeurExo Sciences and Henry Ford present preclinical data on exosomes at ISEV2019
(Henry Ford Health System) NeurExo Sciences, LLC and Henry Ford Health System today announced the presentation of new data on exosomes at the International Society for Extracellular Vesicles (ISEV) 2019 Annual Meeting being held April 24-28, 2019 in Kyoto, Japan. Among their key findings, Henry Ford researchers demonstrated the ability of exosomes to suppress chemotherapy-induced peripheral neuropathy and enhance the anti-tumor effects of platinum drugs, which are commonly used to treat cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 26, 2019 Category: International Medicine & Public Health Source Type: news
